Sandra Sha, M.D., a distinguished physician as recognized by the Florida Medical Association, specializing in breast cancer treatment

Sandra Sha, M.D.


September 8, 2020 — Advanced Radiation Therapy has completed the installation of the AccuBoost Digital platform at the Central Florida Cancer Institute (CFCI). This innovation in breast brachytherapy leverages the superior resolution of digital mammography for the delivery of breast radiation therapy. Along with improvements to treatment workflow, AccuBoost Digital delivers images in real-time with unparalleled clarity. This provides clinical treatment teams with excellent imaging for precise target localization, maximizing the sparing of healthy tissues and organs from undesired radiation. The clinical team at CFCI has over a decade of experience in offering the AccuBoost treatment on the first-generation platform and has seen excellent clinical results. CFCI has acquired the new AccuBoost Digital breast brachytherapy solution with the goal of improving the treatment workflow, reducing treatment time, improving the patient experience, and to benefit from the updated user interface.

Sandra Sha, M.D., a distinguished physician as recognized by the Florida Medical Association, specializing in breast cancer treatment, commented, “Our purchase of the AccuBoost Digital solution is the latest technology update we have added to bring the most advanced breast cancer treatment technologies to the women of Central Florida. Having seen excellent clinical results in our use of the AccuBoost technique for over a decade, we wanted to add the capabilities and benefits this new release offers to our patients.”

Lead therapist and long time AccuBoost user, Michele Jolly, added, “After only a couple days of use, the advantages of the new low profile design have already been realized. Patient setup, particularly for heavier patients, is much easier, and the revised patient flow is very efficient.”

For more information: www.accuboost.com


Additional Content

News | Women's Health

Oct. 29, 2026 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive ...

Time October 30, 2026
arrow
News | Radiopharmaceuticals and Tracers

Oct. 19, 2026 — Nuclidium AG, a clinical-stage radiopharmaceutical company, and NorthStar Medical Technologies, a global ...

Time October 19, 2026
arrow
News | Women's Health

Oct. 15, 2026— SimBioSys has announced U.S. Food and Drug Administration (FDA) 510(k) clearance of TumorSight Risk, its ...

Time October 19, 2026
arrow
News | Breast Imaging

Oct. 6, 2026 — The American College of Radiology (ACR) has recognized Mercy Medical Center’s Tyanna O’Brien Center for ...

Time October 09, 2026
arrow
News | Ultrasound Women's Health

Sept. 29, 2026 — A research team at the University of Virginia (UVA) led by Timothy Bullock, PhD, has published results ...

Time September 30, 2026
arrow
Subscribe Now